Adaptive Biotechnologies Corporation ADPT
Set alert
At close · Oct 30
After hours · Oct 30, 4:12 PM ET
- YTD
- +64.04%
- 1 year
- +57.54%
- Open
- 27.36
- Prev close
- 28.17
- Mkt cap
- 4.25B
- Vol
- 4.26M
- Avg vol
- 2.15M
- EPS
- -0.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.17
- High
- 27.97
- Forward P/E
- -147.76
- Beta
- 2.10
- Short ratio
- 4.56
- Inst. own
- 99.06%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.35
- 200-d avg
- 19.56
- 1y target
- 30.21
2Y chart
Events in this range
- Aug 5, 2025Earnings: -0.17; estimate -0.24; surprise 29.17%
- Nov 6, 2025Earnings: 0.06; estimate -0.18; surprise 133.33%
- Feb 5, 2026Earnings: -0.09; estimate -0.19; surprise 52.63%
- May 5, 2026Earnings: -0.13; estimate -0.16; surprise 18.75%
- Jul 28, 2026Earnings: -0.25; estimate -0.13361; surprise -87.11%
- Aug 4, 2026Rating: Piper Sandler · Overweight → Overweight
- Sep 22, 2026Rating: BTIG · Buy → Buy
- Sep 29, 2026Rating: Goldman Sachs · — → Buy
- Oct 1, 2026Rating: Guggenheim · Buy → Buy
- Oct 13, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Oct 13, 2026Rating: TD Cowen · Buy → Buy
Signals (115)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| SMA: Bullish | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| RSI: Overbought | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 17, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| RSI: Overbought | Jun 11, 2026 | 4 months ago |
| RSI: Overbought | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 29, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 27, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 5 months ago |
| SMA: Bearish | May 5, 2026 | 6 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 2, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 24, 2026 | 7 months ago |
| RSI: Oversold | Mar 12, 2026 | 7 months ago |
| SMA: Bearish | Mar 11, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 26, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| SMA: Bearish | Dec 30, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 18, 2025 | 10 months ago |
| SMA: Bearish | Dec 5, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 5, 2025 | 11 months ago |
| RSI: Overbought | Nov 24, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 21, 2025 | 11 months ago |
| SMA: Bullish | Nov 19, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 28, 2025 | 1 year ago |
| RSI: Overbought | Oct 20, 2025 | 1 year ago |
| RSI: Overbought | Oct 15, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 30, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 24, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2025 | 1 year ago |
| RSI: Overbought | Aug 15, 2025 | 1 year ago |
| RSI: Overbought | Aug 13, 2025 | 1 year ago |
| RSI: Overbought | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| SMA: Bullish | Jul 22, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 25, 2025 | 1 year ago |
| RSI: Overbought | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| RSI: Overbought | Jun 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 22, 2025 | 1 year ago |
| RSI: Overbought | May 5, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| MACD: Buy Signal | May 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 16, 2025 | 1 year ago |
| SMA: Bearish | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 11, 2025 | 1 year ago |
| SMA: Bearish | Apr 10, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 28, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 20, 2025 | 1 year ago |
| SMA: Bearish | Mar 13, 2025 | 1 year ago |
| SMA: Bullish | Mar 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 7, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 19, 2024 | 1 year ago |
Key statistics
- Market cap
- 4.25B
- Enterprise value
- 4.57B
- Trailing P/E
- 0.00
- Forward P/E
- -147.76
- PEG ratio
- 0.00
- Price / sales
- 13.80
- Price / book
- 29.67
- EPS (TTM)
- -0.41
- Beta
- 2.10
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -20.73%
- Revenue (TTM)
- 308.08M
- Revenue growth
- 21.50%
- Free cash flow
- 18.98M
- Total cash
- 344.26M
- Total debt
- 410.50M
- Return on equity
- -38.76%
- Shares outstanding
- 159.60M
- Short % of float
- 9.49%
- 50-day average
- 26.35
- 200-day average
- 19.56
Analyst view
Consensus: strong buy
- Target (low)
- 21.00
- Target (mean)
- 30.21
- Target (high)
- 35.00
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate -0.09552.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | -0.09108 | — | — | — |
| Jul 28, 2026 | Jun 30, 2026 | -0.13361 | -0.25 | -0.12 | -87.11% |
| May 5, 2026 | Mar 31, 2026 | -0.16 | -0.13 | +0.03 | +18.75% |
| Feb 5, 2026 | Dec 31, 2025 | -0.19 | -0.09 | +0.10 | +52.63% |
| Nov 6, 2025 | Sep 30, 2025 | -0.18 | 0.06 | +0.24 | +133.33% |
| Aug 5, 2025 | Jun 30, 2025 | -0.24 | -0.17 | +0.07 | +29.17% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | main | Buy | Buy |
| Oct 13, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Oct 1, 2026 | Guggenheim | main | Buy | Buy |
| Sep 29, 2026 | Goldman Sachs | init | — | Buy |
| Sep 22, 2026 | BTIG | main | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | main | Overweight | Overweight |
About Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- adaptivebiotech.com
News
- Adaptive Biotechnologies: Getting Paid Every Step Of The Way To A Myeloma Cure
- Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 11,881 Shares of Company Stock
- Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 11,881 Shares of Stock
- MercadoLibre, Banco Bradesco, Itaú Unibanco And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
- Alger Small Cap Focus Fund Q3 2026 Portfolio Update
- Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $304,272.41 in Stock
- Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
- TD Cowen Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $32
- Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Raises Price Target to $27
- Adaptive Biotechnologies Corp (ADPT) Stock Down 3.5% but Still Overvalued -- GF Score: 68/100
Your note
Sign in to keep a note on ADPT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENZENO SHARON | Officer | Sale | Jun 28, 2026 | 221,278 |
| BOBULSKY SUSAN | Officer | Sale | Oct 5, 2026 | 389,350 |
| LO FRANCIS | Officer | Sale | Sep 30, 2026 | 223,367 |
| NEUPERT PETER M | Director | Sale | Aug 16, 2026 | 130,625 |
| OWEN KATEY EINTERZ | Director | Stock Gift | Aug 30, 2026 | 66,100 |
| PELLINI MICHAEL J | Director | Stock Award(Grant) | Mar 3, 2025 | 69,690 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Viking Global Investors, L.P. | 18.79% | 29,993,708 | 799.03M | Jun 29, 2026 |
| Blackrock Inc. | 9.49% | 15,139,159 | 403.31M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.01% | 6,403,587 | 170.59M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.70% | 5,911,366 | 157.48M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 3.43% | 5,476,231 | 145.89M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 2.90% | 4,625,859 | 123.23M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.03% | 4,834,309 | 128.79M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.58% | 4,122,023 | 109.81M | Sep 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 1.14% | 1,825,333 | 48.63M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.09% | 1,742,854 | 46.43M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.06% | 1,684,998 | 44.89M | Jul 30, 2026 |
| ALGER FUNDS-Alger Small Cap Focus Fund | 0.94% | 1,494,214 | 39.81M | Jul 30, 2026 |